Administration of rituximab and methylprednisolone ( DrugBank: Rituximab, Methylprednisolone )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1

51. 全身性強皮症

---

臨床試験数 : 523 /  薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00379431 (ClinicalTrials.gov)	November 2006	20/9/2006	A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab	A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab	Early and Severe Systemic Sclerosis	Drug: Administration of rituximab and methylprednisolone	University Hospital, Ghent	NULL	Active, not recruiting	18 Years	N/A	Both	40	Phase 2	Belgium